The Peer Genetic Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

149 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-08

Study Completion Date

2024-09-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial studies how well a peer-based health education program works in reducing barriers and changing attitudes and beliefs of prostate cancer genetic screening in African American participants with or without a previous personal or family history of prostate cancer. Participating in a peer-based health educational program may help participants learn more about prostate cancer and how their personal or family history of disease may increase their risk of prostate cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Web-Based Lifestyle Intervention for the Improvement of Health in African American Cancer Survivors

NCT04290962

Cancer Survivor

WITHDRAWN NA

GENErating Behavior Change, An Integrative Health Coaching and Genetic Risk Testing Pilot

NCT01766271

Coronary Heart Disease Risk

COMPLETED NA

African American Cancer Prevention Project: Establishing a Cohort to Investigate Health Disparities

NCT00823394

Cancer

UNKNOWN

The Rural African American's Health Project

NCT04501471

SAAF-T FUEL for Families

COMPLETED PHASE2

Diet & Activity Community Trial: High-Risk Inflammation

NCT01760902

Inflammation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subject Prostate Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (health education)

Participants attend 1-2 monthly peer educator-led education sessions about PCA genetic testing over 3 hours each for 18 months.

Group Type EXPERIMENTAL

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Educational Intervention

Intervention Type OTHER

Attend peer-led education sessions

Arm II (cancer educational materials)

Participants receive mailed informational materials about PCA risk, family history, and genetic testing.

Group Type ACTIVE_COMPARATOR

Cancer Educational Materials

Intervention Type BEHAVIORAL

Receive prostate cancer educational materials

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cancer Educational Materials

Receive prostate cancer educational materials

Intervention Type BEHAVIORAL

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Educational Intervention

Attend peer-led education sessions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Able to read and speak English comfortably
* With or without a personal or family history of PCA
* Do not need to be an established patient at CityLife Neighborhood Clinic in order to participate